nucleotid
variabl
sequenc
gene
encod
transmembran
protein
canin
coronaviru
ccv
describ
total
faecal
sampl
pup
enter
analys
pcr
npcr
specif
ccv
four
sampl
collect
dog
present
longdur
shed
ccv
sampl
anoth
diarrhoeic
dog
found
posit
pcr
neg
npcr
sequenc
analysi
sampl
reveal
silent
nucleotid
substitut
bind
site
intern
primer
use
npcr
moreov
nucleotid
substitut
occur
whole
fragment
five
sampl
analys
similar
loss
appetit
lethargi
occasion
sudden
death
younger
pup
canin
coronaviru
ccv
member
corona
isol
ccv
infect
dog
often
difficult
frequent
coronaviruslik
particl
virida
famili
first
isol
epizoot
germani
case
canin
enter
seen
electron
microscopi
em
stool
difficult
propag
problem
isol
ccv
serolog
genet
relat
coronavirus
felin
infecti
periton
ccv
still
hinder
studi
epidemiolog
pathogenesi
viru
fipv
felin
enter
coronaviru
fecv
transmiss
gastroenter
viru
tgev
porcin
resrec
pcr
npcr
develop
diagnosi
ccv
overcam
difficulti
piratori
coronaviru
prcv
natur
occur
infect
pup
six
viru
isol
vitro
origin
pcr
npcr
assay
base
heminest
strategi
week
old
appear
suscept
diseas
may
relat
declin
pair
primer
use
pcr
chosen
wellconserv
region
gene
ccv
matern
antibodi
young
pup
ccv
appear
replic
primarili
enterocyt
villu
tip
abl
amplifi
also
fipv
tgev
strain
primer
pair
use
npcr
abl
amplifi
small
intestin
also
epithelium
larg
intestin
excret
faec
ccv
tgev
strain
use
heminest
strategi
abl
detect
ccv
rna
ccv
may
caus
diarrhoea
vomit
dehydr
higher
sensit
approxim
vestig
occasion
find
sequenc
sampl
display
unusu
respons
npcr
assay
determin
analys
germani
ml
supernat
fraction
sampl
target
sequenc
amplif
segment
materi
method
nucleotid
gene
encod
transmembran
protein
ccv
revers
transcriptas
rt
perform
total
reaction
volum
l
contain
total
faecal
sampl
dog
examin
buffer
kcl
mm
trishcl
mm
ph
mgcl
sampl
group
follow
sampl
mm
mm
deoxynucleotid
datp
dctp
collect
period
month
dgtp
dttp
rnase
inhibitor
u
rt
u
pmol
store
b
sampl
fresh
rectal
primer
antisens
cdna
synthes
swab
collect
pup
enter
c
faecal
carri
min
follow
desampl
collect
approxim
everi
three
natur
step
min
day
dog
recov
ccv
enter
pcr
reaction
total
volum
l
kept
observ
period
nine
month
contain
buffer
mgcl
mm
mm
deoxynucleotid
amplitaq
gold
dna
polymeras
u
pmol
primer
sens
virolog
examin
carri
cycl
dna
thermal
cycler
perkin
elmer
cetu
norwalk
usa
folonli
rectal
swab
group
b
c
low
reaction
paramet
templat
denatur
subject
viral
isol
sampl
min
primer
anneal
min
homogen
dulbeccominim
essenti
extens
min
singl
final
extens
medium
dmem
clarifi
centrifug
step
done
min
complet
g
min
supernat
amplif
reaction
sampl
treat
antibiot
iuml
penifor
npcr
l
aliquot
dilut
cillin
gml
streptomycin
gml
amof
first
amplicon
subject
second
round
photericin
min
inocul
onto
amplif
use
primer
partial
confluent
monolay
canin
cell
cultur
pcr
cycl
procedur
incub
vv
co
amplifi
product
electrophores
incub
sampl
consid
neg
wv
agaros
gel
v
min
ccv
three
passag
cytopath
effect
cpe
stain
ethidium
bromid
sequenc
observ
presenc
cpe
isol
posit
primer
shown
tabl
identifi
indirect
immunofluoresc
assay
ifa
use
monoclon
antibodi
moab
coronavirus
sampl
examin
group
group
c
cpcr
nestedpcr
npcr
sampl
group
c
collect
respect
two
month
faecal
sampl
test
ccv
pcr
npcr
previous
report
briefli
specimen
five
month
presum
primari
infect
dog
sampl
dilut
phosphatebuff
salin
pb
homogenis
vigor
vortex
inneg
npcr
sequenc
analysi
also
perform
pcr
amplicon
sampl
solubl
compon
remov
centrifug
min
g
genom
rna
extract
collect
pup
onset
enter
result
expect
posit
npcr
use
rneasi
total
rna
kit
qiagen
gmbh
collect
dog
long
shed
sampl
collect
respect
two
five
month
onset
enter
moreov
sampl
slightli
differ
sampl
cthe
rtpcr
amplicon
obtain
primer
pair
purifi
ultrafreeda
figur
column
amicon
millipor
sequenc
directli
abipr
perkin
elmer
appli
biosystem
instrument
sampl
sequenc
discuss
twice
sequenc
analysi
perform
ncbi
embl
analysi
tool
align
se
glycoprotein
coronavirus
transmembran
molecul
deepli
embed
viral
quenc
perform
clustal
w
align
compar
analysi
publish
sequenc
envelop
small
region
expos
outer
surfac
lipid
bylay
function
gene
ccv
strain
insavc
access
number
use
essenti
coronavirus
bud
rough
endoplasm
reticulum
rer
golgi
membran
antibodi
glycoprotein
neutral
viral
infect
presenc
compleresult
ment
moment
signific
variat
four
ccv
strain
faecal
sampl
examin
group
b
c
isol
observ
gene
glycoprotein
ccv
complet
clear
leaderprim
replic
cell
two
isol
made
group
b
two
isol
made
pup
kept
transcript
coronaviru
rna
result
high
frequenc
recombin
also
mutat
observ
group
c
sampl
collect
three
five
day
onset
enter
isol
rna
polymeras
would
probabl
introduc
one
mutat
everi
round
induc
typic
lytic
cpe
coronaviru
three
day
incub
cell
result
posit
replic
long
genom
coronavirus
gener
consequ
great
deal
genet
ifi
test
use
moab
tabl
report
result
pcr
nvariat
progeni
coronavirus
one
infect
individu
high
degre
genet
varipcr
analysi
ccv
group
sampl
result
posit
pcr
assay
ation
fecv
rna
alreadi
reveal
sequenc
analysi
gene
posit
npcr
assay
fresh
sampl
pup
enter
group
b
result
posit
denatur
gradient
gel
electrophoresi
pcr
amplicon
n
gene
suggest
pcr
npcr
assay
twentytwo
sampl
collect
pup
kept
obfelin
coronaviru
exist
quasispeci
find
studi
though
base
limit
servat
group
c
result
posit
pcr
sampl
npcr
interestingli
shed
ccv
number
sampl
short
fragment
ccv
rna
suggest
high
degre
variat
occur
intermitt
period
nine
month
five
rectal
swab
one
group
genom
ccv
also
exist
studi
five
sampl
found
posit
four
pup
kept
observ
group
c
result
posit
pcr
unexpectedli
neg
npcr
though
npcr
sensit
pcr
assay
pcr
neg
npcr
sequenc
analysi
five
sampl
reveal
repetit
nucleotid
subal
sampl
exhibit
similar
variat
bind
site
intern
primer
use
stitut
bind
site
intern
primer
though
nucleotid
variat
npcr
one
nucleotid
variat
occur
terminu
primer
bind
site
determin
amino
acid
chang
data
shown
sequenc
five
pcr
amplicon
result
import
stabil
primer
anneal
regard
sampl
highli
similar
sever
mutat
observ
sampl
occur
pothre
substitut
region
terminu
case
may
suppos
sition
sampl
